Anzeige
Mehr »
Login
Dienstag, 03.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Eilmeldung: Goldshores aggressiver Winter-Explorationsplan nimmt Gestalt an
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
245 Leser
Artikel bewerten:
(0)

Solis Mammography Offers Four Compelling Reasons to Start Annual Mammograms at Age 40

Finanznachrichten News

ADDISON, TX / ACCESSWIRE / March 6, 2018 / Turning 40 is a benchmark birthday for many women in the United States. While a pessimist might view it as a signal that their glory days are over, more and more women are optimistic about the milestone, seeing it as a kickoff into the best years of their lives. But one thing is true for all women - health needs and preventative wellness routines should begin to change at age 40.

"For some women, they have health history or specific reasons to begin mammography before age 40. But for the average woman who has never had a breast screening, we recommend she begin a routine annual wellness mammogram, starting at age 40," said Dr. Stephen Rose, chief medical officer, Solis Mammography. "Simply put, women in their 40s have the most to gain from being proactive about early detection. Major studies have shown time and again that in addition to saving lives, early detection offers greater quality of life as treatment at earlier stages is less invasive and less costly."

Solis Mammography is expected to complete nearly 1 million procedures in 2018. Making them the nation's largest independent provider of breast screening services. With this, Solis Mammography has some of the nation's most comprehensive research data supporting its claim that women should begin annual mammography starting at age 40. This is in contrast to some confusing and conflicting advice from various media and non-physician-led organizations.

"While it's true that breast cancer treatment has come a long way in recent years, this should in no way deter a woman from participating in the benefits of annual mammography," said Solis Mammography CEO James Polfreman. "The fact is that cell growth replicates at a faster rate in younger tissue. So, the younger you are, the more important it is to find any anomaly earlier. Research and technological advances in mammography have led to an all-time high in survival rates from breast cancer diagnosis. This tells us we're on the right path, and annual mammography is a key part of that success story."

Four Compelling Reasons to Begin Annual Mammograms at 40

  1. The numbers. According to the American Cancer Society, 20 percent of all breast cancers are found in women under 50. If the cancer is found early, in what is known as stage zero or stage one, the five-year survival rate is nearly 100 percent. Simply stated, early detection is the closest thing to a cure, and mastectomies are no longer the first line of defense.
  2. Women in their 40s have the most to gain. "Today's high-quality screenings benefit 40-year-old women the most," explained Dr. Rose, a radiologist with more than 25 years in the field of breast screening specialization, involved in several published national studies. "Advancements like 3-D mammography (digital breast tomosynthesis), and breast specialization have a significant impact on the quality of the mammography result. Today, we know one mammogram isn't the same as another. It's important to know what to look for in your provider to ensure the most accurate results."
  3. A chance for women to take charge of their health. Conflicting recommendations from some non-physician led organizations have suggested a "reasonable trade-off" to the "fear, anxiety and stress" of a "false positive" (otherwise known as a recall for additional images) is to delay annual screenings for five to 10 critical years. This advice encourages a foolhardy "Russian Roulette" approach to monitoring breast health. It suggests no alternative to mammography; instead suggesting screenings be ignored entirely. The studies and clinical evidence are clear. Early detection provides women with the greatest opportunity for long-term survival and quality of life through the least invasive treatment when caught at the earliest possible stage.
  4. Treatment is an option; knowledge is not. Instead of focusing on overdiagnosis as the problem, the real question at hand is overtreatment. With the advancement of medicine and less invasive treatments, women have more options for success. And in some cases, patients may opt not to treat at all, rather to monitor changes over time. These are discussions a woman can and should have with her doctor AFTER getting all the facts. Avoiding the facts is not a solution.

Pea versus Walnut: Why Mammograms Help with Early Detection

Dr. Rose suggests thinking of a pea versus a walnut when considering why early detection is so important. The average size of a lump found in a woman who gets regular annual mammograms is the size of a pea. The size of a lump found by a woman who does only occasional self-exams is the size of a walnut.

"Imagine the difference in treating the pea versus the walnut. It's the pea that gives us our best options for treatment," Dr. Rose advised. "Put simply, the larger the lump, the more invasive and costly the treatment options become, and the more risk that is associated with long-term outcomes."

About Solis Mammography

With more than 32 years dedicated to breast health, Solis Mammography is a specialized healthcare provider focused on delivering patients an exceptional experience and exceptionally accurate results in mammography and screening services. Headquartered in Addison, Texas, Solis Mammography operates 45 centers across six major markets - North Texas; Houston; Phoenix; Columbus, Ohio; Greensboro, North Carolina; and, through its affiliated brand Washington Radiology, Washington D.C., Maryland and Virginia. The company operates both wholly-owned centers and multiple successful joint ventures with hospital partners. Completing 700,000 procedures last year, both Solis Mammography and Washington Radiology offer dedicated experts in breast screening and diagnostic mammography (2-D and 3-D), breast ultrasound, stereotactic biopsy and ultrasound-guided biopsy. In addition, Washington Radiology offers a full range of diagnostic services including general ultrasound, general biopsy, X-ray, MRI and CT screening. For more information, visit www.SolisMammo.com, like us on Facebook, follow us on Pinterest, and subscribe to our YouTube channel.

Media Contact:

Jo Trizila,
TrizCom Public Relations
Jo@TrizCom.com
office: 972-247-1369 or cell: 214-232-0078

SOURCE: Solis Mammography

© 2018 ACCESSWIRE
Treibt Nvidias KI-Boom den Uranpreis?
In einer Welt, in der künstliche Intelligenz zunehmend zum Treiber technologischer Fortschritte wird, rückt auch der Energiebedarf, der für den Betrieb und die Weiterentwicklung von KI-Systemen erforderlich ist, in den Fokus.

Nvidia, ein Vorreiter auf dem Gebiet der KI, steht im Zentrum dieser Entwicklung. Mit steigender Nachfrage nach leistungsfähigeren KI-Anwendungen steigt auch der Bedarf an Energie. Uran, als Schlüsselkomponente für die Energiegewinnung in Kernkraftwerken, könnte dadurch einen neuen Stellenwert erhalten.

Dieser kostenlose Report beleuchtet, wie der KI-Boom potenziell den Uranmarkt beeinflusst und stellt drei aussichtsreiche Unternehmen vor, die von diesen Entwicklungen profitieren könnten und echtes Rallyepotenzial besitzen

Handeln Sie Jetzt!

Fordern Sie jetzt den brandneuen Spezialreport an und profitieren Sie von der steigenden Nachfrage, der den Uranpreis auf neue Höchststände treiben könnte.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.